Drug intelligence / Profile preview

TSHA-115

Development stage
Preclinical
Lead developer
Taysha Gene Therapies
Modality
Gene Therapies
Administration
Not Disclosed (gene Therapies Are Typically Intravenous, Intrathecal, Or Intramuscular Based On The Indication, But This Is Not Specified For TSHA-115)
01

Overview

TSHA-115 is an investigational **gene therapy** developed by Taysha Gene Therapies for the treatment of **glycogen storage diseases**. It is designed to utilize a microRNA (miRNA)-regulated delivery system to provide therapeutic benefit in affected tissues[9][11]. The specific genetic modification, target gene(s), and underlying mechanism are not fully public, but based on Taysha’s general platform, TSHA-115 likely uses an **adeno-associated virus (AAV) vector** system for gene delivery and regulation in metabolic disease tissues. These features may allow for tissue-selective expression and reduced off-target effects, though details remain preclinical.

Brand names
TSHA-115TSHA115TSHA 115
Other names
TSHA-115TSHA115TSHA 115

Beyond the preview

Go deeper on TSHA-115.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TSHA-115.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call